Cargando…
RETRACTED ARTICLE: Qilongtian ameliorate bleomycin-induced pulmonary fibrosis in mice via inhibiting IL-17 signal pathway
Pulmonary fibrosis (PF) is a special type of pulmonary parenchymal disease, with chronic, progressive, fibrosis, and high mortality. There is a lack of safe, effective, and affordable treatment methods. Qilongtian (QLT) is a traditional Chinese prescription that is composed of Panax notoginseng, Ear...
Autores principales: | Zhang, Qiang, Luo, Ting, Yuan, Dezheng, Liu, Jing, Fu, Yi, Yuan, Jiali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092933/ https://www.ncbi.nlm.nih.gov/pubmed/37045911 http://dx.doi.org/10.1038/s41598-023-31439-5 |
Ejemplares similares
-
Retraction Note: Qilongtian ameliorate bleomycin-induced pulmonary fibrosis in mice via inhibiting IL-17 signal pathway
por: Zhang, Qiang, et al.
Publicado: (2023) -
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
por: Wilson, Mark S., et al.
Publicado: (2010) -
Hyperbaric Oxygen Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Yuan, Yuan, et al.
Publicado: (2021) -
17(R)‐resolvin D1 ameliorates bleomycin‐induced pulmonary fibrosis in mice
por: Yatomi, Masakiyo, et al.
Publicado: (2015) -
IL-22 inhibits bleomycin-induced pulmonary fibrosis in association with inhibition of IL-17A in mice
por: Qu, Ziye, et al.
Publicado: (2022)